EUCTR2006-002564-25-IT进行中（未招募）不适用
A PHASE II MULTICENTER STUDY OF BORTEZOMIB, THALIDOMIDE, PEGHILATED LIPOSOMAL DOXORUBICIN, DEXAMETHASONE (ThaDD-V)IN PATIENTS AFFECTED BY RELAPSED-REFRACTORY MULTIPLE MYELOMA - ND
AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI0 个研究点开始时间: 2007年7月13日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1-Realapsed-refractory multiple myeloma (MM)
- •2-Less or equal 2 previuos chemotherapy regimens
- •3-Age <= 80 years
- •4-Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1-De novo or treated with > 2 chemotherapy regimens MM
- •2-Pregnant or lactated women
- •3-Refuse of contracceptive methods
- •4-Neuropathy > grade 2
- •5-Inadequate cardiac, hepatic, bone marrow and cerebral functions
- •6-Other active or in remission from <5 years neoplasia
研究者
相似试验
进行中（未招募）
不适用
A PHASE II, MULTI-CENTER STUDY OF BORTEZOMIB, ADRIAMYCIN, DEXAMETHASONE (PAD) as induction and MELPHALAN 100 mg/m2 (MEL 100) as transplant, IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.Treatment in elderly newly diagnosed multiple myeloma patientsMedDRA version: 9.1Level: LLTClassification code 10028228Term: Multiple myelomaEUCTR2005-004714-32-ITFONDAZIONE NEOPLASIE SANGUE ONLUS
进行中（未招募）
不适用
PHASE II TRIAL OF BORTEZOMIB (VELCADE) IN COMBINATION WITH CHLORAMBUCIL IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTROM?S MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMA. A MULTICENTER STUDY. - NDWALDENSTROM?S MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMAMedDRA version: 9.1Level: LLTClassification code 10003908Term: B-cell small lymphocytic lymphomaEUCTR2006-003495-35-ITISTITUTO EUROPEO DI ONCOLOGIA
进行中（未招募）
1 期
PHASE II TRIAL OF BORTEZOMIB (VELCADE®) IN PATIENTS WITH ADVANCED OR RELAPSED LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT)EUCTR2005-003077-25-ATAKH Vienna16
进行中（未招募）
1 期
A study in which is investigated if the medicine bortezomib is effective in patients with AL amyloidosisEUCTR2010-021445-42-NLHOVON Foundation50
进行中（未招募）
不适用
A PHASE II STUDY OF VELCADE BORTEZOMIB - PS341 IN THE TREATMENT OF PATIENTS OVER 18 YEARS WITH Ph LEUKEMIApatients over 18 years with Ph leukaemiaMedDRA version: 9.1Level: LLTClassification code 10009013Term: Chronic myeloid leukaemiaEUCTR2004-002977-22-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI